Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2007-09-25
2007-09-25
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S185100, C424S190100, C424S234100, C424S249100, C424S250100
Reexamination Certificate
active
09684883
ABSTRACT:
The identification of a highly conserved, immunologically accessible antigen on the surface ofNeisseriafacilitates treatment, prophylaxis, and diagnosis ofNeisseriadiseases. This antigen is highly resistant to proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from threeNeisseria meningitidisstrains and from oneNeisseria gonorrhoaeastrain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of theNeisseriasurface protein, and antibodies that bind to this protein are also disclosed.
REFERENCES:
patent: 4879213 (1989-11-01), Fox et al.
patent: 5106726 (1992-04-01), Wang
patent: 6287574 (2001-09-01), Brodeur et al.
patent: 0 273 116 (1988-07-01), None
patent: 0474 313 (1992-03-01), None
patent: 0301992 (1995-05-01), None
patent: 0474313 (1997-04-01), None
patent: 94/05703 (1994-03-01), None
Plokin et al. (VaccinesW.B. Saunders Co. Philadelphia, PA p. 571), 1988.
Hilde-Kari Guttormsen, et al., “Humoral Immune Response to Class 1 Outer Membrane Protein during the Course of Meningococcal Disease”, 62 Infection and Immunity 4, 1437, 1443 (1994).
Frasch et al., “Serotype Antigens of Neisseria Meningitidis and A Proposed Scheme For Designation of Serotypes”,Review of Infectious Diseases, vol. 7(4):504-510, (1985).
Reingold et al., “Age-Specific Differences In Duration Of Clinical Protection After Vaccination With Menningococcal Polysaccharide A Vaccine”,The Lancet, pp. 114-118, (1985).
Zollinger, “New And Improved Vaccines Against Meningococcal Disease”, pp. 325-348, (1990).
Frasch, “Status Of A Group B Neisseria Meningitidis Vaccine”Eur. J. Clin. Microbiol., vol. 4(6):533-536, (1985).
Frasch et al. “Antibody Response of Adults To An Aluminum Hydroxide-Adsorbed Neisseria Meningitidis Serotype 2b Protein-Group B. Polysaccharide Vaccine”,The Journal Of Infectious Diseases, vol. 158(4):710-718, (1988).
Moreno et al., “Immunity And Protection Of Mice Against Neisseria Meningitidis Group B By Vaccination, Using Polysaccharide Complexed With Outer Membrane Proteins: A Comparison With Purified B Polysaccharide”Infection And Immunity, vol. 47(2):527-533, (1985).
Rosenzvist et al., “Antibody Responses To Serogroup B Meningococcal Outer Membrane Antigens After Vaccination And Infection”,Journal Of Clinical Microbiology, vol. 26(8): 1543-1548, (1988).
Wedege et al., “Human Antibody Response To A Group B Serotype 2a Meningococcal Vaccine Determined By Immunoblotting”,Infection And Immunity, vol. 51(2):571-578, (1986).
Wedege et al., “Human Immunoglobulin G Subclass Immune Response To Outer Membrane Antigens In Meningococcal Group B Vaccine”,Journal Of Clinical Microbiology, vol. 25(8):1349-1353, (1987).
Zollinger et al., “Complex Of Meningococcal Group B Polysaccharide and Type 2 Outer Membrance Protein Immunogenic In Man”The Journal Of Clinical Investigation, vol. 63:836-848, (1979).
Frasch, “Vaccines For Prevention Of Meningococcal Disease”,Clinical Microbiology Review, vol. 2:S134-S138, (1989).
Munkley et al., “Blocking Of Bacericidal Killing Of Neisseria Meningitidis By Antibodies Directed Against Class 4 Outer Membrane Protein”,Microbial Pathogenesis, vol. 11:447-452, (1991).
Woods et al., “Resistance to Meningococcemia Apparently Conferred by Anti-H.8 Monoclonal Antibody Is Due To Contaminating Endotoxin And Not To Specific Immunoprotection”,Infection And Immunity, vol. 55(8):1927-1928, (1987).
Nicholson et al., “Outer Membrane Proteins Of Three Pathogenic Leptospira Species”,Veterinary Microbiology, vol. 36:123-138, (1993).
Butler et al., “Identification And Characterization Of Proteinase K-Resistant Proteins In Members Of The Class Mollicutes”,Infection And Immunity, vol. 59(3):1037-1042, (1991).
Bastian et al., “Antiserum To Scrapie-Associated Fibril Protein Cross-Reacts With Spiroplasma Mirum Fibril Proteins”,Journal of Clinical Microbiology, vol. 25(12):2430-2431, (1987).
Prusiner et al., “Attempts To Restore Scrapie Prion Infectivity After Exposure To Protein Denaturants”,Proc. Natl. Acad. Sci. USA, vol. 90:2793-2797, (1993).
Onodera et al., “Isolation Of Scrapie Agent From The Placenta Of Sheep With Natural Scrapie In Japan”,Microbiol. Immunol., vol. 37(4):311-316, (1993).
Brodeur et al., “Protection Against Infection With Neisseria Meningitidis Group B Serotype 2b By Passive Immunization With Serotype-Specific Monoclonal Antibody”Infection And Immunity, vol. 50(2):510-516, (1985).
Martin et al., “Immunological Characterization Of The Lipooligosaccharide B Band Of Bordetella Pertusis”,Infection and Immunity, vol. 60:(7):2718-2725, (1992).
Lussier et al., “Detection of Neisseria Gonorrhoeae By Dot-Enzyme Immunoassay Using Monoclonal Antibodies”,Journal of Immunoassay, vol. 10(4):373-394, (1989).
Brodeur et al., “Mouse Models Of Infection For Neisseria Meningitidis B,2b And Haemophilus Influenzae Type b Diseases”,Can. J. Microbiol., vol. 32:33-37, (1986).
Wang et al., “Clonal And Antigenic Analysis Of Serogroup A Neisseria Meningitidis With Particular Reference To Epidemiological Features Of Epidemic Meningitis In The People's Republic of China”,Infection And Immunity, vol. 60(12):5267-5282, (1992).
Martin et al., “Mapping Of B-Cell Epitopes On The Outer Membrane P2 Porin Protein Of Haemophilus Influenzae By Using Recombinant Proteins And Synthetic Peptides”Infection and Immunity, vol. 59(4): 1457-1464, (1991).
Kupsch et al., “Variable Opacity (Opa) Outer Membrane Proteins Account For The Cell Tropisms Displayed By Neisseria Gonorrhoeae For Human Leukocytes And Epithelial Cells”,The EMBO Journal, vol. 12(2):641-650, (1993).
Bhat et al., “The Opacity Proteins Of Neisseria Gonorrhoeae Strain MS11 Are Encoded By A Family Of 11 Complete Genes”,Molecular Microbiology, vol. 6(8): 1073-1076, (1992).
Bhat et al., “The Opacity Proteins Of Neisseria Gonorrhoeae Strain MS11 Are Encoded By A Family Of 11 Complete Genes”,Molecular Microbiology, vol. 5(8):1889-1901, (1991).
Wolff et al. “Identification and Characterization of Specific Sequences Encoding Pathogenicity Associated Proteins in the Genome of CommensalNeisseriaSpecies”FEMS Microbiology Letters125: 255-264 (1995).
Sacchi et al. “Considerations on the Use ofNeisseria MeningitidiesClass 5 Proteins As Meningococcal BC Vaccine Components”Vaccine13: 112-118 (1995).
Strittmatter et al. “Isolation and Preliminary Biochemical Characterization of the Gonococcal H.8 Antigen”Journal of Experimental Medicine164: 2038-2048 (Dec. 1986).
Poolman et al. “Immunogenicity of Meningococcal Antigens as Detected in Patient Sera”Infection and Immunity40: 398-406 (1983).
Aho et al., “A Comparative Analysis of Pilin Genes from Pathogenic and NonpathogenicNeisseriaSpecies,”Microbial Pathogenesis 28:81-88, 2000.
Bernardini et al., “Proteome Analysis ofNeisseria meningitidisSerogroup A,”Proteomics 4:2893-2926, 2004.
Bhattacharjee et al., “Purification and Characterization of H.8 Antigen from Group BNeisseria meningitidis,”Infection and Immunity 56(4):773-778, 1988.
Bjune et al., “Effect of Outer Membrane Visicle Vaccine Against Group B Meningococcal Disease in Norway,”The Lancet 338(8775):1093-1096, 1991.
Drocourt et al., “Nucleotide Sequence of the Xylose Isomerase Gene fromStreptomyces Violaceoniger”Nucleic Acids Research 16(19):9337, 1988.
Frasch et al., “Immune Responses of Adults and Children to Group BNeisseria meningitidisOuter Membrane Protein Vaccines,”in Bacterial Vaccines262-272, 1987.
Frasch et al.,
Brodeur Bernard R.
Hamel Josee
Martin Denis
Rioux Clement
ID Biomedical Corporation
Navarro Mark
Seed IP Law Group PLLC
LandOfFree
Proteinase K resistant surface protein of neisseria... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteinase K resistant surface protein of neisseria..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteinase K resistant surface protein of neisseria... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3758224